Search
Restoring Effective Anti-Tumor Response in Hodgkin Lymphoma with Nivolumab
Hodgkin Lymphoma typically affects young men and women in their 30s. Although it is highly curable with the current combination of chemo and radiation therapy, approximately 20% of patients will not be cured with first line regimens.
Read moreInternational Call to Action to Alleviate Drug Shortages
The common call to action seeks first to raise awareness of shortages of drugs among hematologists.
Read moreMore than science: the European Affairs program at EHA2023
To develop and administer safe, innovative and effective treatments for patients with blood diseases, hematologists need an effective and enabling regulatory environment.
Read moreProcedure & Reports
Structure and proceduresEHA encourages scientists in hematology to submit an application to create a scientific network with a specific interest field and supports knowledge exchange under the umbrella of EHA.
Read morePublication of EHA Annual General Meeting 2023 minutes
EHA impact video
The 2023 EHA Annual General Meeting (AGM) took place in Frankfurt, Germany on June 9, 2023.